0.1595
Azitra Inc stock is traded at $0.1595, with a volume of 1.16M.
It is up +7.05% in the last 24 hours and down -28.70% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.149
Open:
$0.15
24h Volume:
1.16M
Relative Volume:
0.58
Market Cap:
$3.30M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0071
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-2.74%
1M Performance:
-28.70%
6M Performance:
-61.72%
1Y Performance:
-76.01%
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AZTR
Azitra Inc
|
0.1595 | 3.08M | 1.27M | -11.28M | -10.46M | -22.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Azitra Inc Stock (AZTR) Latest News
Pattern recognition hints at Azitra Inc. upsideStop Loss & Long-Term Growth Stock Strategies - Newser
Is Azitra Inc.’s ROE strong enoughJuly 2025 EndofMonth & Reliable Breakout Forecasts - mustnews.co.kr
Signal strength of Azitra Inc. stock in tech scannersWeekly Trend Report & Entry and Exit Point Strategies - Newser
Earnings visualization tools for Azitra Inc.July 2025 Short Interest & AI Driven Stock Reports - Newser
Using data models to predict Azitra Inc. stock movementProfit Target & Consistent Profit Alerts - Newser
Price action breakdown for Azitra Inc.Treasury Yields & Community Consensus Trade Signals - Newser
How institutional ownership impacts Azitra Inc. stock2025 Major Catalysts & Community Trade Idea Sharing - Newser
Volatility clustering patterns for Azitra Inc.Market Risk Report & Low Risk High Win Rate Stock Picks - Newser
Does Azitra Inc. qualify in momentum factor screening2025 Performance Recap & Real-Time Volume Analysis - Newser
Azitra Inc. recovery potential after sell offFed Meeting & Safe Entry Zone Tips - Newser
Why Azitra Inc. is moving todayWeekly Stock Report & Daily Profit Maximizing Tips - Newser
Should you wait for a breakout in Azitra Inc.Weekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
Applying Elliott Wave Theory to Azitra Inc.July 2025 Price Swings & Reliable Breakout Forecasts - Newser
Why Azitra Inc. stock attracts strong analyst attentionTrade Analysis Report & Reliable Entry Point Trade Alerts - Newser
Is Azitra Inc. stock good for income investorsDip Buying & High Conviction Buy Zone Alerts - mustnews.co.kr
Using fundamentals and technicals on Azitra Inc.Analyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Relative strength of Azitra Inc. in sector analysis2025 Key Highlights & Technical Pattern Based Signals - Newser
Azitra (NYSEAMERICAN:AZTR) Shares Set to Reverse Split on Friday, August 22nd - Defense World
How to build a dashboard for Azitra Inc. stockJuly 2025 Setups & AI Enhanced Trading Signals - Newser
Using flow based indicators on Azitra Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Azitra Inc (AZTR) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Azitra Reports Q2 Net Loss of $2.9 Million, Cash on Hand at $1.0 Million - AInvest
MACD Signals Flash Warning for Azitra Inc. StockStep-by-Step Trade Signal Implementation Guide Ready - 선데이타임즈
Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates - PR Newswire
Azitra's Breakthrough: Promising Safety Results in Netherton Syndrome Treatment Trial as Pipeline Advances - Stock Titan
Azitra authorizes reverse 1-for-6.66 stock split - TipRanks
Azitra announces 1-for-6.66 reverse stock split effective August 21 - Investing.com
Azitra Reports Q2 2025 Results, 50% Enrollment in Phase 1b Trial for ATR-12 Program. - AInvest
Azitra Reduces Share Count by 85%: Key Details of 1-for-6.66 Reverse Split Revealed - Stock Titan
Using RSI to spot recovery in Azitra Inc.Technical Trend Forecast for Investors - Newser
What makes Azitra Inc. stock price move sharplyFree Stock Portfolio Allocation Guidance - Newser
What MACD signals say about Azitra Inc.Day Trading Setup Forecast with Trend Model - Newser
How Azitra Inc. stock performs during market volatilityChart Driven Entry Timing for Swing Trades - Newser
Azitra Inc.’s volatility index tracking explainedEntry Signal Generator with Risk Metrics - Newser
Published on: 2025-08-10 20:17:51 - Newser
Sector ETF Data Correlates with Strength in Azitra Inc.Accurate Buy Point for Momentum Stocks Detected - beatles.ru
Azitra (AZTR) to Release Quarterly Earnings on Monday - Defense World
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cap:
|
Volume (24h):